Crossmark

CYP2D6-guided opioid therapy improves pain control in CYP2D6 intermediate and poor metabolizers: a pragmatic clinical trial

Crossref DOI link: https://doi.org/10.1038/s41436-018-0431-8

Published Print: 2019-08

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Smith, D. Max

Weitzel, Kristin W.

Elsey, Amanda R.

Langaee, Taimour

Gong, Yan

Wake, Dyson T.

Duong, Benjamin Q.

Hagen, Melanie

Harle, Christopher A.

Mercado, Elvira

Nagoshi, Ying

Newsom, Kimberly

Wright, Ashleigh

Rosenberg, Eric I.

Starostik, Petr

Clare-Salzler, Michael J.

Schmidt, Siegfried O.

Fillingim, Roger B.

Johnson, Julie A.

Cavallari, Larisa H.
License Information

Text and Data Mining valid from 2019-08-01

Text and Data Mining valid from 2019-08-01

Version of Record valid from 2022-01-19
More Information

This article is maintained by: Elsevier

Article Title: CYP2D6-guided opioid therapy improves pain control in CYP2D6 intermediate and poor metabolizers: a pragmatic clinical trial

Journal Title: Genetics in Medicine

CrossRef DOI link to publisher maintained version: https://doi.org/10.1038/s41436-018-0431-8

Content Type: article

Copyright: © 2019, The Author(s), under exclusive licence to the American College of Medical Genetics and Genomics